Krishna Jadhav

524 total citations
25 papers, 325 citations indexed

About

Krishna Jadhav is a scholar working on Pulmonary and Respiratory Medicine, Pharmaceutical Science and Molecular Biology. According to data from OpenAlex, Krishna Jadhav has authored 25 papers receiving a total of 325 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Pulmonary and Respiratory Medicine, 11 papers in Pharmaceutical Science and 6 papers in Molecular Biology. Recurrent topics in Krishna Jadhav's work include Inhalation and Respiratory Drug Delivery (10 papers), Advanced Drug Delivery Systems (7 papers) and Drug Solubulity and Delivery Systems (4 papers). Krishna Jadhav is often cited by papers focused on Inhalation and Respiratory Drug Delivery (10 papers), Advanced Drug Delivery Systems (7 papers) and Drug Solubulity and Delivery Systems (4 papers). Krishna Jadhav collaborates with scholars based in India, United States and Canada. Krishna Jadhav's co-authors include Rahul Kumar Verma, Eupa Ray, Kalpesh Vaghasiya, Raghuraj Singh, Om Prakash Katare, Ankur Sharma, Jitendra Naik, Rehan Khan, Aniruddha Chatterjee and Rahul Shukla and has published in prestigious journals such as SHILAP Revista de lepidopterología, ACS Applied Materials & Interfaces and Journal of Controlled Release.

In The Last Decade

Krishna Jadhav

24 papers receiving 322 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Krishna Jadhav India 11 124 108 92 77 52 25 325
Eupa Ray India 14 109 0.9× 103 1.0× 159 1.7× 137 1.8× 130 2.5× 20 470
Alaa S. Tulbah Saudi Arabia 14 96 0.8× 134 1.2× 77 0.8× 43 0.6× 137 2.6× 30 384
Abdul Baseer Pakistan 12 35 0.3× 85 0.8× 89 1.0× 43 0.6× 43 0.8× 40 399
Rana B. Bakhaidar Saudi Arabia 14 41 0.3× 172 1.6× 73 0.8× 42 0.5× 63 1.2× 30 415
Kiran Jyoti India 13 65 0.5× 118 1.1× 137 1.5× 61 0.8× 110 2.1× 16 365
Richard T. Addo United States 12 30 0.2× 135 1.3× 103 1.1× 75 1.0× 118 2.3× 21 419
Hongxia Lin South Korea 8 128 1.0× 156 1.4× 72 0.8× 66 0.9× 114 2.2× 9 464
Taylor L. Carlson United States 9 54 0.4× 157 1.5× 35 0.4× 58 0.8× 183 3.5× 14 498
Makbule Aşıkoğlu Türkiye 11 60 0.5× 82 0.8× 65 0.7× 35 0.5× 33 0.6× 31 298

Countries citing papers authored by Krishna Jadhav

Since Specialization
Citations

This map shows the geographic impact of Krishna Jadhav's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Krishna Jadhav with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Krishna Jadhav more than expected).

Fields of papers citing papers by Krishna Jadhav

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Krishna Jadhav. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Krishna Jadhav. The network helps show where Krishna Jadhav may publish in the future.

Co-authorship network of co-authors of Krishna Jadhav

This figure shows the co-authorship network connecting the top 25 collaborators of Krishna Jadhav. A scholar is included among the top collaborators of Krishna Jadhav based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Krishna Jadhav. Krishna Jadhav is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Rojekar, Satish, Amol D. Gholap, Krishna Jadhav, et al.. (2025). Exploring Protein Aggregation in Biological Products: From Mechanistic Understanding to Practical Solutions. AAPS PharmSciTech. 26(6). 189–189. 2 indexed citations
2.
Jadhav, Krishna, Dipak D. Gadade, Anand Iyer, et al.. (2025). Peptide–Drug Conjugates as Next-Generation Therapeutics: Exploring the Potential and Clinical Progress. Bioengineering. 12(5). 481–481. 5 indexed citations
3.
Jadhav, Krishna, et al.. (2025). Intelligently Actuating Dual-Barrier Hyaluronic Acid-Functionalized Inflammation-Responsive Nanohydrogel for Targeted Rheumatoid Arthritis Therapy. ACS Applied Materials & Interfaces. 17(28). 40012–40034. 1 indexed citations
4.
Jadhav, Krishna, et al.. (2025). Host-Directed Therapy with Inhalable Lovastatin Microspheres for Matrix Metalloproteinase Inhibition in Tuberculosis. ACS Applied Bio Materials. 8(2). 1533–1546. 3 indexed citations
6.
Jadhav, Krishna, Shripad A. Patil, Satish Rojekar, et al.. (2025). Advances in spray drying technology for anti-tubercular formulation development: A comprehensive review. Drying Technology. 43(1-2). 53–89. 4 indexed citations
7.
Ray, Eupa, et al.. (2024). Inhalable chitosan-coated nano-assemblies potentiate niclosamide for targeted abrogation of non-small-cell lung cancer through dual modulation of autophagy and apoptosis. International Journal of Biological Macromolecules. 279(Pt 4). 135411–135411. 5 indexed citations
8.
Jadhav, Krishna, et al.. (2024). Breaking the Cycle: Matrix Metalloproteinase Inhibitors as an Alternative Approach in Managing Tuberculosis Pathogenesis and Progression. ACS Infectious Diseases. 10(8). 2567–2583. 5 indexed citations
9.
Jadhav, Krishna, et al.. (2024). Recent Developments in Tyrosine Kinase Inhibitor-based Nanotherapeutics for EGFR-resistant Non-small Cell Lung Cancer. Current Drug Delivery. 22(3). 249–260. 10 indexed citations
10.
Jadhav, Krishna, Saroja Kumar Rout, Rahul Kumar Verma, et al.. (2024). A critical review on developments in drying technologies for enhanced stability and bioavailability of pharmaceuticals. Drying Technology. 42(9). 1415–1441. 15 indexed citations
11.
Jadhav, Krishna, et al.. (2024). Effective cerebral tuberculosis treatment via nose-to-brain transport of anti-TB drugs using mucoadhesive nano-aggregates. Nanoscale. 16(35). 16485–16499. 7 indexed citations
12.
Jadhav, Krishna, Raghuraj Singh, Shweta Sharma, et al.. (2024). Trans-nasal brain delivery of anti-TB drugs by methyl-β-cyclodextrin microparticles show efficient mycobacterial clearance from central nervous system. Journal of Controlled Release. 378. 671–686. 6 indexed citations
14.
Ray, Eupa, et al.. (2024). Targeted delivery of the metastasis-specific tumour homing TMTP1 peptide to non-small-cell lung cancer (NSCLC) using inhalable hybrid nano-assemblies. Journal of Materials Chemistry B. 12(38). 9740–9759. 6 indexed citations
15.
Jadhav, Krishna, Zia Ul Haq Khan, Rahul Kumar Verma, et al.. (2024). Engineered vildagliptin-loaded polymeric nanoparticles via microfluidic and spray drying for enhanced antidiabetic activity. SHILAP Revista de lepidopterología. 10(1). 3 indexed citations
16.
Panghal, Archna, Krishna Jadhav, Ashima Thakur, et al.. (2024). Recent Advances in Targeting Transition Metals (Copper, Iron, and Zinc) in Alzheimer’s Disease. Molecular Neurobiology. 61(12). 10916–10940. 14 indexed citations
17.
Jadhav, Krishna, et al.. (2023). Nanotherapeutics for pulmonary drug delivery: An emerging approach to overcome respiratory diseases. Journal of Drug Delivery Science and Technology. 81. 104261–104261. 43 indexed citations
18.
Jadhav, Krishna, Raghuraj Singh, Eupa Ray, et al.. (2023). Clofazimine nanoclusters show high efficacy in experimental TB with amelioration in paradoxical lung inflammation. Biomaterials Advances. 154. 213594–213594. 20 indexed citations
19.
Jakhar, Deepak, Raghuraj Singh, Krishna Jadhav, et al.. (2023). Fat fighting liraglutide based nano-formulation to reverse obesity: Design, development and animal trials. International Journal of Pharmaceutics. 634. 122585–122585. 20 indexed citations
20.
Vaghasiya, Kalpesh, Eupa Ray, Raghuraj Singh, et al.. (2021). Efficient, enzyme responsive and tumor receptor targeting gelatin nanoparticles decorated with concanavalin-A for site-specific and controlled drug delivery for cancer therapy. Materials Science and Engineering C. 123. 112027–112027. 82 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026